Profil

Mievis Frédéric

See author's contact details
Main Referenced Co-authors
Giacomelli, Fabrice  (26)
Bahri, Mohamed Ali  (23)
Lemaire, Christian  (22)
Salmon, Eric  (22)
Luxen, André  (21)
Main Referenced Keywords
SV2A (14); epilepsy (7); PET (7); [18F]UCB-H (5); SV2 (5);
Main Referenced Unit & Research Centers
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège [BE] (19)
GIGA-CRC in vivo imaging, Nucleis (1)
Memory Clinic (CHU Liège) (1)
UCB Pharma (1)
Main Referenced Disciplines
Radiology, nuclear medicine & imaging (22)
Neurosciences & behavior (4)
Laboratory medicine & medical technology (3)
Oncology (2)
Life sciences: Multidisciplinary, general & others (2)

Publications (total 28)

The most downloaded
453 downloads
Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5 https://hdl.handle.net/2268/76679

The most cited

91 citations (Scopus®)

Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5 https://hdl.handle.net/2268/76679

Bastin, C., Bahri, M. A., Giacomelli, F., Miévis, F., Lemaire, C., Degueldre, C., Balteau, E., Guillaume, B., & Salmon, E. (2021). Familiarity in Mild Cognitive Impairment as a function of patients’ clinical outcome four years later. Alzheimer Disease and Associated Disorders, 35 (4), 321-326. doi:10.1097/WAD.0000000000000466
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpre, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (2020). Exploring with [(18)F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. Molecular Imaging and Biology. doi:10.1007/s11307-020-01488-7
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2019). Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value. Molecular Imaging and Biology, 21, 888-897. doi:10.1007/s11307-018-1301-0
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., Salmon, E., Raedt, R., & Plenevaux, A. (18 October 2018). THE SV2A PROTEIN: IMAGING SYNAPTIC DENSITY DURING THE PROGRESSION OF THE TEMPORAL LOBE EPILEPSY IN THE KASE RAT MODEL [Poster presentation]. MINC 2018 – Multimodal Neuroimaging Cologne, Köln, Germany.

Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20th EURON PhD days, Brussels, Belgium.

Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20TH EURON PhD DAYS, Leuven, Belgium.

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., & Plenevaux, A. (22 March 2018). [18F]UCB-H BINDING QUANTIFICATION IN RAT BRAIN: FROM MODELLING TO SUV [Poster presentation]. 13th European Molecular Imaging Meeting - EMIM 2018, San Sebastián, Spain.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (December 2017). Sv2a protein levels in the kainic acid epilepsy rat model during the acute phase. Epilepsia, 58 (Supplement S5), 1–S225.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 February 2017). Evaluating the specificity of [18F] UCB-H for the isoform SV2A, compared with isoforms SV2B and SV2C [Poster presentation]. GIGA Day 2017, Liège, Belgium.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). [18F]UCB-H RADIOTRACER AS A TOOL TO UNDERSTAND THE ROLE OF THE SV2A PROTEIN [Poster presentation]. PhD Student Day, Liège, Belgium.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN AN EPILEPTIC RAT MODEL [Poster presentation]. 3rd Belgium Molecular Imaging Congress (BMIC 2017), Brussels, Belgium.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN THE KAINIC ACID EPILEPSY RAT MODEL [Poster presentation]. 12th European Molecular Imaging Meeting (EMIM 2017), Cologne, Germany.

Serrano Navacerrada, M. E., Aerts, J., Bahri, M. A., Becker, G., Giacomelli, F., Lemaire, C., Luxen, A., Mercier, J., Mestdagh, N., Mievis, F., Plenevaux, A., Salmon, E., & Warnier, C. (18 November 2016). EVALUATING THE SPECIFICITY OF [18F]UCB-H FOR THE ISOFORM SV2A, COMPARED WITH ISOFORMS SV2B AND SV2C [Poster presentation]. MedChem 2016 PET & Imaging : From Chemistry Lab to Clinical Applications, Mont-Saint-Guibert, Belgium.

Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (09 March 2016). EVALUATION OF SV2Alox/Cre TRANSGENIC MICE USING [18F]UCB-H IN VITRO AUTORADIOGRAPHY [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands.

WITHOFS, N., Martinive, P., VANDERICK, J., BLETARD, N., SCAGNOL, I., Mievis, F., Giacomelli, F., Coucke, P., Delvenne, P., Cataldo, D., Gambhir, S. S., & HUSTINX, R. (2016). [18F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3219-y
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (04 September 2015). EVALUATION OF SV2Alox/Cre TRANSGENIC MOUSE USING [18F]UCB-H IN IN VITRO AUTORADIOGRAPHY [Poster presentation]. International Symposium "Aging and sleep: Perks for longevity?, Liège, Belgium.

Bahri, M. A., Stifkens, M., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., ... SALMON, E. (09 May 2015). [18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial. Tijdschrift voor Nucleaire Geneeskunde, 37 (3), 1457-1458.
Peer reviewed

WITHOFS, N., SIGNOLLE, N., SOMJA, J., LOVINFOSSE, P., MUTIJIMA NZARAMBA, E., Mievis, F., Giacomelli, F., WALTREGNY, D., CATALDO, D., GAMBHIR, S. S., & HUSTINX, R. (2015). 18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: Correlation with histopathology. Journal of Nuclear Medicine. doi:10.2967/jnumed.114.149021
Peer Reviewed verified by ORBi

Bahri, M. A., Stifkens, M., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., ... SALMON, E. (27 January 2015). [18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial [Poster presentation]. 2015 GIGA day, Liège, Belgium.

Bretin, F., Bahri, M. A., BERNARD, C., Warnock, G., Aerts, J., Mestdagh, N., Buchanan, T., Otoul, C., Koestler, F., Mievis, F., Giacomelli, F., Degueldre, C., Hustinx, R., Luxen, A., Seret, A., Plenevaux, A., & Salmon, E. (17 January 2015). Biodistribution and radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H: First-in-human study. Molecular Imaging and Biology, 17, 557-564. doi:10.1007/s11307-014-0820-6
Peer Reviewed verified by ORBi

WITHOFS, N., CHARLIER, E., Simoni, P., Alvarez-Miezentseva, V., Mievis, F., Giacomelli, F., Mella, C., Gambhir, S. S., Malaise, O., DE SENY, D., MALAISE, M., & HUSTINX, R. (2015). (18)F-FPRGD2 PET/CT imaging of musculoskeletal disorders. Annals of Nuclear Medicine, 29 (10), 839-47. doi:10.1007/s12149-015-1011-5
Peer Reviewed verified by ORBi

Warnock, G., Aerts, J., Bahri, M. A., Bretin, F., Lemaire, C., Giacomelli, F., Mievis, F., Mestdagh, N., Buchanan, T., Valade, A., Mercier, J., Wood, M., Gillard, M., Seret, A., Luxen, A., SALMON, E., & Plenevaux, A. (01 August 2014). Evaluation of [18F]UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain. Journal of Nuclear Medicine, 55 (8), 1336-1341. doi:10.2967/jnumed.113.136143
Peer Reviewed verified by ORBi

Bahri, M. A., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., Plenevaux, A., & Salmon, E. (06 June 2014). [18F]UCB-H AS A NEW PET RADIOTRACER FOR SYNAPTIC VESICLE PROTEIN 2A [Poster presentation]. European Molecular Imaging Meeting - EMIM 2014, Antwerp, Belgium.

Bahri, M. A., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Mievis, F., Léonard, M., Seret, A., Luxen, A., Plenevaux, A., & Salmon, E. (27 May 2014). [18F]UCB-H AS A BRAIN SV2A RADIOTRACER: A FIRST CLINICAL TRIAL [Poster presentation]. XIII Turku PET Symposium, Turku, Finland.

Bastin, C., Bahri, M. A., Mievis, F., Lemaire, C., Collette, F., Genon, S., Simon, J., Guillaume, B., Diana, R. A., Yonelinas, A. P., & Salmon, E. (2014). Associative memory and its cerebral correlates in Alzheimer’s disease: Evidence for distinct deficits of relational and conjunctive memory. Neuropsychologia, 63, 99-106. doi:10.1016/j.neuropsychologia.2014.08.023
Peer Reviewed verified by ORBi

Bretin, F., Warnock, G., Bahri, M. A., Aerts, J., Mestdagh, N., Buchanan, T., Valade, A., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., Salmon, E., Seret, A., & Plenevaux, A. (07 May 2013). Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H. EJNMMI Research, 3 (1), 35. doi:10.1186/2191-219X-3-35
Peer Reviewed verified by ORBi

WITHOFS, N., MARTINIVE, P., SCAGNOL, I., THONON, D., Giacomelli, F., Mievis, F., COUCKE, P., CATALDO, D., Gambhir, S., & HUSTINX, R. (2012). Preliminary results of (18F)FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. Journal of Nuclear Medicine, 53 (SUPPL), 1703.
Peer Reviewed verified by ORBi

Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5
Peer Reviewed verified by ORBi

Contact ORBi